+ All Categories
Home > Documents > Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo.,...

Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo.,...

Date post: 18-Feb-2018
Category:
Upload: lamtruc
View: 220 times
Download: 3 times
Share this document with a friend
52
Malnutrition: Where are we headed? Kris M. Mogensen, MS, RD-AP, LDN, CNSC Team Leader Dietitian Brigham and Women’s Hospital Instructor Boston University College of Health and Rehabilitation Sciences: Sargent College [email protected]
Transcript
Page 1: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Malnutrition:

Where are we headed?

Kris M. Mogensen, MS, RD-AP, LDN, CNSC

Team Leader Dietitian

Brigham and Women’s Hospital

Instructor

Boston University College of Health and Rehabilitation Sciences:

Sargent College

[email protected]

Page 2: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Disclosures

• I have no disclosures related to this

topic

Page 3: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

• It helps to look back before we look

forward, so:

– Review prior malnutrition efforts

– What’s happening with Academy-

ASPEN characteristics

– Where are we headed?

Objectives

Page 4: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Kickin’ it Old School

Page 5: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

JAMA 1936

Page 6: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Nutrition Today

1974

Page 7: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

JPEN

1977 – Issue 1!!

Page 8: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

SGA!

Page 9: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

“Old” Evaluation Parameters

• % IBW

• % UBW

• Presence of fat/muscle wasting

• Presence of edema

• Adequacy of intake

• Circulating proteins

• Anergy

• Other direct anthropometric measurements

Page 10: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Old Malnutrition Diagnoses

• Kwashiorkor

• Marasmus

• Mild, moderate, severe protein-calorie

malnutrition

• Protein-calorie malnutrition, NOS

Old Malnutrition Diagnoses

Page 11: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Blast from the Past!

From ~ 1992!

Page 12: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

# of

Criteria Wt loss IBW wasting

Inadequate

energy intake Albumin*

Severe PCM 3 > 15% in 6

mo. < 70% yes yes < 2.1

Moderate

PCM 2

10%-15%, in

6 mo. 70%-84% no no < 2.7

Mild PCM 2 5%-9% in 6

mo. 85%-94% no no < 3.4

Marasmus 3

5% over one

mo., 7.5

over three

mo., 10%

over six mo.

<94% yes yes WNL or slightly

decreased

Unspecified

PCM

A patient at nutritional risk who may have a single nutrient deficiency,

multiple micronutrient deficiencies, overt fat/muscle wasting without

supporting weight history to fit into another category, prolonged

hypocaloric intake and high metabolic demand, etc.

BWH Old Criteria

*RDs trained not to use if inflammation or other confounder present

Page 13: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Malnutrition Outcomes:

Old Characteristics

CCM 2015

CCM 2015

JPEN epub 2016; print Feb 2017

JPEN epub 2016

Page 14: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.
Page 15: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.
Page 16: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.
Page 17: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.
Page 18: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Moving into modern times…

Page 19: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Etiology-Based Malnutrition Diagnoses

From: White JV et al. Consensus statement: Academy of Nutrition and Dietetics and American

Society for Parenteral and Enteral Nutrition: Characteristics recommended for the identification

and documentation of adult malnutrition (undernutrition). JPEN 2012

Page 20: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

2012 Malnutrition Clinical

Characteristics Parameters

• Insufficient energy intake

• Weight loss

• Loss of muscle mass

• Loss of subcutaneous fat

• Localized or generalized fluid

accumulation that may sometimes mask

weight loss

• Diminished functional status as measured

by hand grip strength From: White JV et al. Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and

Enteral Nutrition: Characteristics recommended for the identification and documentation of adult malnutrition

(undernutrition). JPEN 2012

Page 21: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Evaluation of Energy Intake

Kondrup K. Clin Nutr. 2001

Intake <75%

of needs, no

weight

maintenance

or gain

Page 22: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Weight Loss Evaluation

Page 23: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Physical Examination

Page 24: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Hand Grip Strength

Page 25: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Where are we headed?

First stop: Validation!

Page 26: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Validation of the Academy/ASPEN Malnutrition Clinical

Characteristics. Hand RK et al. JAND 2016

Page 27: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Current research with 2012 Adult

Malnutrition Clinical Characteristics

• Nicolo M et al. Feasibility of accessing data in hospitalized patients to

support diagnosis of malnutrition by the Academy- A.S.P.E.N.

malnutrition consensus recommended clinical characteristics. JPEN

2014;38:954-959

• Hand RK et al. Validation of the Academy/ASPEN Malnutrition Clinical

Characteristics. J Acad Nutr Diet. 2016

• Hiller LD et al. Difference in composite end point of readmission and

death between malnourished and nonmalnourished veterans assessed

using Academy of Nutrition and Dietetics/American Society for

Parenteral and Enteral Nutrition Clinical Characteristics. JPEN epub Sept

2016

• Mulasi U et al. Malnutrition identified by the Academy of Nutrition and

Dietetics and American Society for Parenteral and Enteral Nutrition

consensus criteria and other bedside tools is highly prevalent in a

sample of individuals undergoing treatment for head and neck cancer.

JPEN epub Oct 2016

Page 28: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Feasibility of accessing data in hospitalized patients to

support diagnosis of malnutrition by the Academy-

A.S.P.E.N. malnutrition consensus recommended clinical

characteristics. Nicolo M et al. JPEN 2014

Page 29: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Validation of the Academy/ASPEN

Malnutrition Clinical Characteristics. Hand RK et al. JAND 2016

Clinical Characteristic Evaluated?

Intake 96%

Wgt loss 92%

Muscle 98%

Fat 100%

Edema 98%

Hand grip 64%

28 patients enrolled in the study

Page 30: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Validation of the Academy/ASPEN Malnutrition

Clinical Characteristics. Hand RK et al. JAND 2016

• Was there agreement between RDs?

– 24 of 28 had evaluation done by 2 RDs

• Context: agreed ~ 88% of the time

• Diagnosis: agreed for ~ 67% of pts

Page 31: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Validation of the Academy/ASPEN

Malnutrition Clinical Characteristics. Hand RK et al. JAND 2016

• Full outcome data for 11 pts

– Malnourished pts had

• longer LOS

• higher charges

• more frequent ED visits

• More frequent readmissions

Page 32: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Difference in composite end point of readmission and death between

malnourished and nonmalnourished veterans assessed using

Academy of Nutrition and Dietetics/American Society for Parenteral

and Enteral Nutrition Clinical Characteristics. Hiller LD et al. JPEN epub 2016

• Retrospective medical record review

• Used all characteristics except hand grip

strength

• Matched malnourished vs nonmalnourished:

202 in each group

• Composite end point: 30 day readmission

rate and 90 day mortality rate

Page 33: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Difference in composite end point of readmission and death between

malnourished and nonmalnourished veterans assessed using

Academy of Nutrition and Dietetics/American Society for Parenteral

and Enteral Nutrition Clinical Characteristics. Hiller LD et al. JPEN epub 2016

Page 34: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Difference in composite end point of readmission and death between

malnourished and nonmalnourished veterans assessed using

Academy of Nutrition and Dietetics/American Society for Parenteral

and Enteral Nutrition Clinical Characteristics. Hiller LD et al. JPEN epub 2016

Page 35: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Comparisons to other

markers…

Page 36: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Malnutrition Identified by the Academy of Nutrition and Dietetics and

American Society for Parenteral and Enteral Nutrition Consensus

Criteria and Other Bedside Tools is Highly Prevalent in a Sample of

Individuals Undergoing Treatment for Head and Neck Cancer. Mulasi U et al. JPEN epub 2016

Page 37: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Malnutrition Identified by the Academy of Nutrition and Dietetics and

American Society for Parenteral and Enteral Nutrition Consensus

Criteria and Other Bedside Tools is Highly Prevalent in a Sample of

Individuals Undergoing Treatment for Head and Neck Cancer. Mulasi U et al. JPEN epub 2016

Page 38: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Validation, refining the

characteristics, and

more…where do we go from

here?

Page 39: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Functional Status and

Outcomes

CCM 2016

Surgery 2016

Page 40: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Functional Status and

Outcomes • Formal PT assessment using the

Functional Independence Measure

– Independent, low, intermediate, high, and very

high risk

• High & very high risk

– Increased odds of 90-day post-discharge

mortality in ICU and trauma patients

– Higher prevalence of malnutrition in these

groups

Page 41: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.
Page 42: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Crit Care

Med. 2016

Page 43: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Functional Status and

Outcomes

• Can we collaborate with other

colleagues evaluating patients? – Could the PT scoring system be part of our

malnutrition characteristics in adults?

– Are our OT colleagues measuring hand grip

strength?

Page 44: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Measures of Muscle Mass

• What are the roles of

– BIA

– CT

– Ultrasound

• Will these move into prime time?

Page 45: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Role of Metabolomics?

Mogensen et al. JPEN

2017

Page 46: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Coding and Data Collection

• We need to continue to work on

getting malnutrition coded

appropriately

• Not just a $$$ issue, but allows for

ongoing research for prevalence and

outcomes

Page 47: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Data Collection and Storage

• If you are still in your building phase

of your EHR or you actually have

programmers who want to work with

you…

– Document data in a structured format

– Limit free text for data

Page 48: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.
Page 49: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Treatment of Malnourished

Patients

• Is there a difference in clinical

response in malnourished vs. well

nourished patients?

• How do we study this?

Page 50: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.
Page 51: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Conclusions

• Validation studies of current malnutrition

characteristics are in progress

• Will there be refinement of these characteristics

in the future?

• Keep collecting data and outcomes! Push for

appropriate coding!

• I hope that future research includes other

evaluation tools to expand the characteristics

• Finally, my hope is that future research evaluates

impact of nutrition interventions for malnourished

patients

Page 52: Malnutrition: Where are we headed? symposium... · Marasmus 3 5% over one mo., 7.5 over three mo., 10% over six mo.

Thank you!


Recommended